Interviews

DirectorsTalk Interviews brings investors closer to the people behind listed companies, markets and sectors. We feature interviews with CEOs from UK, US and Canadian companies, alongside fund managers, analysts and sector specialists, giving audiences direct insight into strategy, performance, opportunities and risks. Each interview is designed to help investors understand the businesses shaping the market and make more informed decisions.

Quadrise Fuels bioMSAR™ Aquafuels testing results endorsement of potential (Interview)

Quadrise Fuels International plc (LON:QFI) CEO Jason Miles joins DirectorsTalk Interviews to discuss the results of the latest bioM-SAR™ testing at Aquafuel Research and also the appointment of Andy Morrison..

Fintel digitisation of SaaS & subscription business improves earnings quality (Analyst Interview)

Fintel plc (LON:FNTL) is the topic of conversation when Robin Savage, Research Analyst at Zeus Capital joins DirectorsTalk Interviews. Robin talks us through the key points in the company pre-close..

Staffline Group positive momentum to continue into FY22 (Analyst Interview)

Staffline Group plc (LON:STAF) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital joins DirectorsTalk Interviews. Mike explains who Staffline Group are, what makes them..

LSL Property Services has considerable value and strategically positioned (Analyst Interview)

LSL Property Services plc (LON:LSL) is the topic of conversation when Robin Savage, Research Analyst at Zeus Capital joins DirectorsTalk Interviews. Robin talks us through the key points in the..

Safestyle UK should outperform peers in the sector (Analyst Interview)

Safestyle UK plc (LON:SFE) is the topic of conversation when Andy Hanson, Research Director at Zeus Capital joins DirectorsTalk Interviews. Andy explains how Safestyle UK traded during the year, the..

Goodbody Health a pivotal moment in community pharmacy (Interview)

Goodbody Health Inc. (CSE:GDBY / AQSE:GDBY / FRA: 484 / OTC: SCNNF) Scientific Advisory Committee Member and Chair of the Pharmacy Focus Group Ian Strachan joins DirectorsTalk Interviews to tell..

N4 Pharma encouraging data, oncology the quickest route to clinic (Interview)

N4 Pharma plc (LON:N4P) CEO Nigel Theobald joins DirectorsTalk to discuss encouraging data from its oncology research. Nigel describes the behavior of Nuvec, explains why now a focus on oncology,..

Lookers cheap shares and exciting new strategy (Analyst Interview)

Lookers plc (LON:LOOK) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital joins DirectorsTalk Interviews. Mike talks us through the key points from the company’s..

AMTE Power expected to be key beneficiary of ATF in Gigafactory plans (Analyst Interview)

AMTE Power plc (LON:AMTE) is the topic of conversation when WH Ireland Senior Analyst Matthew Davis joins DirectorsTalk Interviews. Matthew explains why its been a busy week for the battery..

Epwin Group “valuation is really appealing” (Analyst Interview)

Epwin Group plc (LON:EPWN) is the topic of conversation when Research Director at Zeus Capital, Andy Hanson joins DirectorsTalk Interviews. With Epwin Group having announced its year-end trading update in..

Ilika in a strong cash position to go through to commercialisation (Analyst Interview)

Ilika plc (LON:IKA) is the topic of conversation when partner and clean-tech equities specialist at Baden Hill, Dr Tom McColm joins DirectoirsTalk Interviews. With Ilika providing a half-year report for..

Anexo Group deliver strong revenues with significant opportunities ahead (Interview)

Anexo Group plc (LON:ANX) Head of Investor Relations Nick Dashwood Brown joins DirectorsTalk Interviews to discuss a trading Update for the year ended 31st December 2021. Nick explains why fleet..

City of London Investment Group very reliable with an attractive dividend (Analyst Interview)

City of London Investment Group plc (LON: CLIG) is the topic of conversation when Robin Savage joins DirectorsTalk Interviews. Robin shares his thoughts on the interim trading update for the..

Boku becomes pure-play payments company as growth continues (Interview)

Boku Inc. (LON:BOKU) CEO Jon Prideaux joins DirectorsTalk Interviews to discuss an agreement for the divestment of Boku Identity and a trading update for the financial year ended 31st December..

CentralNic Group ahead of analysts’ forecasts again (Interview)

CentralNic Group plc (LON:CNIC) CEO Ben Crawford joins DirectorsTalk Interviews to discuss forth quarter and full year results. With the FY delivering revenue growth of 70% and adjusted EBITDA growth..

Helium One CEO David Minchin discusses additional helium anomalies, share price and horizon (Interview)

Helium One Global plc (LON:HE1) CEO Favid Minchin joins DirectorsTalk Interviews to discuss the completion of a multispectral satellite spectroscopy study which has identified multiple additional surface helium anomalies at..

Poolbeg Pharma in-licencing exciting programmes ready for big pharma (Interview)

Poolbeg Pharma plc (LON:POLB) CEO Jeremy Skillington joins DirectorsTalk Interviews to discuss the in-licencing of a novel, first-in-class RNA-based immunotherapy for respiratory virus infections. Jeremy tells us more about this..

CyanConnode discuss record results, financial projection and priorities in 2022 (Interview)

CyanConnode Holdings plc (LON:CYAN) Executive Chairman John Cronin & CFO Heather Peacock join DirectorsTalk Interviews to discuss trading update for the nine-month period ended 31st December 2021. Heather explains what..

Kenmare Resources CEO: “almost US$100 million shareholder returns in 2021” (Interview)

Kenmare Resources plc (LON:KMR) Managing Director Michael Carvill joins DirectorsTalk Interviews to discuss production results for the full year and for Q4 2021. Michael talks us through the recent safety..

PetroNeft Resources to ramp up operations and news flow (Interview)

PetroNeft Resources plc (LON:PTR) CEO David Sturt joins DirectorsTalk Interviews to discuss the latest company update. David explains the reasons for expanding from 2 wells last year, initially to 5..

Search

Funds

Interviews

Search

Funds

Interviews

FTSE 100

Funds